Johnsson H - Search Results

1

Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertension.

Ekholm M, Wallén NH, Johnsson H, Eliasson K, Kahan T. Ekholm M, et al. Among authors: johnsson h. Clin Sci (Lond). 2002 Aug;103(2):151-5. doi: 10.1042/cs1030151. Clin Sci (Lond). 2002. PMID: 12149106 Clinical Trial.

2

The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis.

He S, Blombäck M, Bark N, Johnsson H, Wallén NH. He S, et al. Among authors: johnsson h. Thromb Haemost. 2010 May;103(5):1076-84. doi: 10.1160/TH09-05-0306. Epub 2010 Mar 9. Thromb Haemost. 2010. PMID: 20216982

3

Letter by Hjemdahl et al regarding article, "Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial".

Hjemdahl P, Johnsson H, Wallén NH. Hjemdahl P, et al. Among authors: johnsson h. Circulation. 2013 Mar 19;127(11):e505. doi: 10.1161/CIRCULATIONAHA.112.135343. Circulation. 2013. PMID: 23509038 No abstract available.

4

A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.

He S, Johnsson H, Zabczyk M, Hultenby K, Cao H, Blombäck M. He S, et al. Among authors: johnsson h. Br J Haematol. 2013 Mar;160(6):806-16. doi: 10.1111/bjh.12189. Epub 2013 Jan 30. Br J Haematol. 2013. PMID: 23360261 Free article.

5

[Raynaud's phenomenon after treatment with beta-blocking agents].

Eliasson K, Johnsson H, Kistner S, Lins LE, Odar-Cederlöf I, Sundqvist K. Eliasson K, et al. Among authors: johnsson h. Lakartidningen. 1978 May 24;75(21):2118-20. Lakartidningen. 1978. PMID: 26828 Swedish. No abstract available.

6

In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway.

Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. Silveira A, et al. Among authors: johnsson h. Arterioscler Thromb Vasc Biol. 1996 Nov;16(11):1333-9. doi: 10.1161/01.atv.16.11.1333. Arterioscler Thromb Vasc Biol. 1996. PMID: 8911271

7

Altered properties of the fibrin gel structure in patients with IDDM.

Jörneskog G, Egberg N, Fagrell B, Fatah K, Hessel B, Johnsson H, Brismar K, Blombäck M. Jörneskog G, et al. Among authors: johnsson h. Diabetologia. 1996 Dec;39(12):1519-23. doi: 10.1007/s001250050607. Diabetologia. 1996. PMID: 8960835

8

Serum lipoproteins and hemostatic function in intermittent claudication.

Johansson J, Egberg N, Johnsson H, Carlson LA. Johansson J, et al. Among authors: johnsson h. Arterioscler Thromb. 1993 Oct;13(10):1441-8. doi: 10.1161/01.atv.13.10.1441. Arterioscler Thromb. 1993. PMID: 8399080

9

Nitroglycerin and haemostasis.

Johnsson H. Johnsson H. Acta Anaesthesiol Scand Suppl. 1992;97:11-4. doi: 10.1111/j.1399-6576.1992.tb03580.x. Acta Anaesthesiol Scand Suppl. 1992. PMID: 1557936 Review. No abstract available.

10

Acute effects with reference to thrombogenicity and liver toxicity after injection of different coagulation factor concentrates.

Schulman S, Johnsson H, Wiman B. Schulman S, et al. Among authors: johnsson h. Haemostasis. 1989;19(3):152-9. doi: 10.1159/000215909. Haemostasis. 1989. PMID: 2568325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page